538 related articles for article (PubMed ID: 10590365)
1. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
2. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
3. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
5. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry.
Leiter U; Buettner PG; Eigentler TK; Bröcker EB; Voit C; Gollnick H; Marsch W; Wollina U; Meier F; Garbe C
J Am Acad Dermatol; 2012 Jan; 66(1):37-45. PubMed ID: 21700361
[TBL] [Abstract][Full Text] [Related]
6. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.
Posther KE; Selim MA; Mosca PJ; Stanley WE; Johnson JL; Tyler DS; Seigler HF
Ann Surg Oncol; 2006 May; 13(5):728-39. PubMed ID: 16538415
[TBL] [Abstract][Full Text] [Related]
8. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.
Francken AB; Shaw HM; Accortt NA; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2007 Jun; 14(6):1924-33. PubMed ID: 17357855
[TBL] [Abstract][Full Text] [Related]
9. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
10. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy and early-stage melanoma.
Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
[TBL] [Abstract][Full Text] [Related]
12. Follow-up schedules after treatment for malignant melanoma.
Francken AB; Accortt NA; Shaw HM; Colman MH; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Br J Surg; 2008 Nov; 95(11):1401-7. PubMed ID: 18844268
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
[TBL] [Abstract][Full Text] [Related]
14. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of patients with a thin melanoma.
Johnson RC; Fenn NJ; Horgan K; Mansel RE
Br J Surg; 1999 May; 86(5):619-21. PubMed ID: 10361181
[TBL] [Abstract][Full Text] [Related]
16. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
17. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785
[TBL] [Abstract][Full Text] [Related]
18. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study.
McCarthy WH; Shaw HM; Thompson JF; Milton GW
Surg Gynecol Obstet; 1988 Jun; 166(6):497-502. PubMed ID: 3375961
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
20. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
